Press Releases

MINNEAPOLIS, Dec. 4, 2019 /PRNewswire/ -- For people with many neurologic disorders, seeing the neurologist by video may be as effective as an in-person visit, according to a review of the evidence conducted by the

HAMPTON, N.H., Dec. 4, 2019 /PRNewswire/ -- Planet Fitness, Inc. (NYSE: PLNT) (the "Company"), today announced that it has entered into a $300 million accelerated share repurchase agreement (the "ASR Agreement") with JPMorgan Chase Bank, National Association ("JP Morgan Chase"). The Company will acquire shares under

LEAGUE CITY, Texas, Dec. 4, 2019 /PRNewswire/ -- Honest Paws announces their new partnership with American Distribution and Manufacturing Company (ADMC). 

DUBLIN, Dec. 4, 2019 /PRNewswire/ -- Allergan plc (NYSE: AGN) today announced that positive results from ACHIEVE I (UBR-MD-01), a robust Phase 3 clinical trial evaluating the efficacy, safety and tolerability of ubrogepant, have been published in the December 5th issue of The New England Journal of Medicine (NEJ

WASHINGTON, Dec. 4, 2019 /PRNewswire/ -- Today, Aurinia Pharmaceuticals Inc. announced very positive top-line results of a Phase III clinical study of voclosporin, a potential new treatment for active lupus nephritis (lupus-related kidney disease). The study met all of its primary and secondary endpoints of achieving complete remission in a statistically significant

FREMONT, Calif., Dec. 4, 2019 /PRNewswire/ -- Ardelyx, Inc. (Nasdaq: ARDX), a specialized biopharmaceutical company focused on developing innovative first-in-class medicines to improve treatment for people with cardiorenal diseases, today announced that it has commenced an underwritten public offering of up to $80,000,000 of shares of its co

JERSEY CITY, N.J., Dec. 4, 2019 /PRNewswire/ -- Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced the presentation of a new analysis examining real-world clinical outcomes of treatment with RADICAVA® (edaravone) in people with ALS at the 30th International Symposium on ALS/MND in Perth, Australia

KING OF PRUSSIA, Pa., Dec. 4, 2019 /PRNewswire/ -- Universal Health Realty Income Trust (NYSE: UHT) announced today that its Board of Trustees voted to increase the quarterly dividend by $.005 and pay a dividend of $.685 per share on December 31, 2019 to shareholders of record

MADISON, Wis. and ROCHESTER, Minn., Dec. 4, 2019 /PRNewswire/ -- Exact Sciences Corp. (NASDAQ: EXAS) today announced Dr. David Ahlquist, co-inventor of Cologuard® and emeritus professor of medicine in the Division of Gastroenterology and Hepatology at Mayo Clinic, has been named a Fellow

NEW YORK and CHICAGO, Dec. 4, 2019 /PRNewswire/ -- RSNA -- RAD Women (#RADxx), a networking group for the advancement of women in imaging infor